Integrated Diagnostics (Egypt) Performance
| IDHC Stock | 20.00 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Integrated Diagnostics are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Integrated Diagnostics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Integrated Diagnostics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Integrated |
Integrated Diagnostics Relative Risk vs. Return Landscape
If you would invest 2,000 in Integrated Diagnostics Holdings on September 28, 2024 and sell it today you would earn a total of 0.00 from holding Integrated Diagnostics Holdings or generate 0.0% return on investment over 90 days. Integrated Diagnostics Holdings is generating negative expected returns and assumes 0.0% volatility on return distribution over the 90 days horizon. Simply put, 0% of stocks are less volatile than Integrated, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Integrated Diagnostics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Integrated Diagnostics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Integrated Diagnostics Holdings, and traders can use it to determine the average amount a Integrated Diagnostics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| IDHC |
Based on monthly moving average Integrated Diagnostics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Integrated Diagnostics by adding Integrated Diagnostics to a well-diversified portfolio.
Things to note about Integrated Diagnostics performance evaluation
Checking the ongoing alerts about Integrated Diagnostics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Integrated Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Integrated Diagnostics generated a negative expected return over the last 90 days |
- Analyzing Integrated Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Integrated Diagnostics' stock is overvalued or undervalued compared to its peers.
- Examining Integrated Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Integrated Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Integrated Diagnostics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Integrated Diagnostics' stock. These opinions can provide insight into Integrated Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Integrated Stock analysis
When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |